HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,023,823 | +5.2% | 111,898 | 0.0% | 0.36% | +9.7% |
Q2 2023 | $9,526,996 | -40.2% | 111,898 | -41.9% | 0.33% | -25.7% |
Q1 2023 | $15,925,982 | -31.9% | 192,459 | -35.3% | 0.44% | -35.2% |
Q4 2022 | $23,396,723 | -59.0% | 297,479 | -61.4% | 0.68% | -60.8% |
Q3 2022 | $57,076,000 | -11.4% | 770,989 | -22.0% | 1.74% | -10.9% |
Q2 2022 | $64,408,000 | +5.4% | 988,149 | +2.2% | 1.96% | +12.8% |
Q1 2022 | $61,102,000 | -5.3% | 966,499 | -20.5% | 1.74% | +1.3% |
Q4 2021 | $64,500,000 | -22.5% | 1,216,059 | +3.1% | 1.72% | -31.7% |
Q3 2021 | $83,272,000 | +31.1% | 1,179,659 | +23.7% | 2.51% | +39.6% |
Q2 2021 | $63,536,000 | – | 953,425 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |